Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ·Healthcare·Biotechnology
$3.75
+0.54%
Mkt Cap $7.91M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$4.00
Range $1.00 – $7.00
Implied Upside
+6.7%
Consensus $4.00 vs current $3.75
NASDAQ·Healthcare·Biotechnology
$3.75
+0.54%
Mkt Cap $7.91M
No recent rating data.
Price Target (2 analysts)
$4.00
Range $1.00 – $7.00
+6.7%
Consensus $4.00 vs current $3.75